RxDoctor Payments Data

Logan Bevill, MD

Family Medicine · Cabot, ARNPI 1598387417

Payments from drug & device makers

$2,780in general payments, 2019–2025

Across 160 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$416
  • AstraZeneca$407
  • Lilly USA, LLC$313
  • GSK$312
  • Pfizer$299
  • Novo Nordisk$259
  • plus $774 from 12 others

What the payments were for

  • Food & beverage$2,73098%
  • Education$502%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,780 in reported general payments places this provider in the 75th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$142,501
Medicare patients
352
Services billed
8,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide117$130,737
JardianceEmpagliflozin103$100,800
Trelegy ElliptaFluticasone/Umeclidin/Vilanter97$71,183
MounjaroTirzepatide52$54,497
FarxigaDapagliflozin Propanediol40$32,299
EliquisApixaban33$30,845
VraylarCariprazine Hcl21$29,649
Breztri AerosphereBudesonide/Glycopyr/Formoterol25$20,523
JanuviaSitagliptin Phosphate24$15,941
UbrelvyUbrogepant15$14,494
CreonLipase/Protease/Amylase13$11,651
LinzessLinaclotide12$10,068
SymbicortBudesonide/Formoterol Fumarate28$6,158
Breo ElliptaFluticasone/Vilanterol14$5,701
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$5,588

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$259$130,737117 claims
Boehringer IngelheimJardiance$18$100,800103 claims
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta$312$82,472123 claims
AbbVieVraylar, Ubrelvy, Creon, Linzess, Synthroid$416$69,421116 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$407$58,98093 claims
Lilly USA, LLCMounjaro$313$54,49752 claims
PfizerEliquis, Dilantin$299$33,16848 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Cabot

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →